HR 3616 United States House · 118th Congress

To direct the Administrator of the Federal Aviation Administration to include medications and medical equipment for the emergency treatment of known or suspected opioid overdose in aircraft emergency medical kits, and for other purposes.

Summary
This bill directs the Federal Aviation Administration (FAA) to require that medications and medical equipment for the emergency treatment of a known or suspected opioid overdose be included in an aircraft emergency medical kit; the FAA must, to the maximum extent possible, follow the guidance of the Aerospace Medical Association. In a 2019 guidance document to the FAA, the Aerospace Medical Association recommended including an opioid antagonist (e.g., naloxone or Narcan) in an aircraft emergency medical kit.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2023
Committee Review
Floor Vote
President
Introduced May 23, 2023 Last action May 24, 2023